Consultation Commercial Success Tracking
Average revenue per unique patient visit by provider, measured against the baseline period
Total Revenue (Baseline)
—
Total Revenue (Current)
—
Avg Rev / Visit (Baseline)
—
Avg Rev / Visit (Current)
—
Change vs Baseline
—
Total Providers
—
Total Revenue Increase
—
Est. EBITDA Increase (18%)
—
Revenue per Visit — Baseline vs Current Period
| Provider | Practice | Title | Base $/Visit | Eff. Base $/Visit | Curr $/Visit | $ Chg | % Chg | Base Visits | Curr Visits | Rev Increase |
|---|
Scenario Inputs
%
%
Baseline Avg $/Visit
—
Projected Avg $/Visit
—
Baseline Annual Visits
—
Projected Annual Visits
—
Projected 12-Mo Revenue
—
Incremental Revenue
—
Provider Revenue Projection
| Provider | Practice | Baseline $/Visit | Projected $/Visit | Baseline Mo. Visits | Projected Mo. Visits | Baseline 12-Mo Rev | Projected 12-Mo Rev | Incremental Rev |
|---|
Projected Visits & Revenue per Visit — 12-Month Outlook
Total Neurotoxin Units (Botox-Equivalent) & Filler Syringes — Monthly
Neurotoxin Units (Botox-Equiv) per Injectables Visit & Filler Syringes per Injectables Visit — Monthly
Filler Sales as % of All Injectables Sales — Monthly
Total Filler Revenue by Month
Total Neurotoxin Revenue by Month
Multisyringe Filler Appointments by Month
Revenue per Utilized Hour — Monthly
Monthly Botox Units & Filler Syringes by Provider
| Month | Provider | Practice | Botox Units | Filler Syringes |
|---|
Metric & Component Definitions
Auto-generated from all components in this application. Definitions update automatically when new cards or charts are added.